Historical Vienna was the scene of this year’s annual congress of the European Society of Cardiology and several important issues in interventional cardiology were addressed.
First, one year after the annual congress in Barcelona, new and follow-up data on drug eluting stent (DES) safety were reported. The nation-wide SCAAR registry compiles data on all percutaneous coronary interventions in Sweden (> 37,000 DES implanted) and at this meeting the 4-year clinical outcomes were presented. Contrary to the 3-year clinical outcomes, a difference in mortality and myocardial infarction favouring bare metal stents (BMS) was no longer observed. Patrick Serruys tried to ...
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next articleThree-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease